1290 Essex Small Cap Growth A holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.
1290 Essex Small Cap Growth Fund Class A ESCFX
- NAV / 1-Day Return 18.47 / +0.10 %
- Total Assets 115.2M
-
Adj. Expense Ratio
1.130%
- Expense Ratio 1.130%
- Distribution Fee Level Below Average
- Share Class Type Front Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 55%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 3:34 AM GMT+0
Morningstar’s Analysis ESCFX
Will ESCFX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Kiniksa Pharmaceuticals International PLC Class A | 2.61 | 3M | Healthcare |
Lincoln Educational Services Corp | 2.53 | 3M | Consumer Defensive |
Leonardo DRS Inc | 2.39 | 3M | Industrials |
JPMorgan Prime Money Market IM | 2.29 | 3M | Cash and Equivalents |
Adaptive Biotechnologies Corp | 2.23 | 3M | Healthcare |
CECO Environmental Corp | 2.08 | 2M | Industrials |
Graham Corp | 1.88 | 2M | Industrials |
Argan Inc | 1.86 | 2M | Industrials |
BrainsWay Ltd ADR | 1.82 | 2M | Healthcare |
Arteris Inc | 1.74 | 2M | Technology |